Condition
Primary Vitreoretinal Lymphoma
Total Trials
3
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
P 2 (1)
P 3 (1)
Trial Status
Unknown2
Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07402876Phase 3RecruitingPrimary
A Clinical Trial Evaluating Patients With Primary Vitreoretinal Lymphoma
NCT05950490UnknownPrimary
Construction of Diagnosis and Treatment System for Primary Vitreoretinal Lymphoma
NCT04899453Phase 2UnknownPrimary
Intravitreal MTX and ZR Regimen in Newly Diagnosed PVRL
Showing all 3 trials